Ellab Acquires ESi
Ellab is expanding in the US with the acquisition of ESi
Today, Ellab announces the merger and acquisition of Evolution Scientific, Inc., (“ESi”) a leading American life sciences technical service company with 25 employees based in Doylestown, Pennsylvania.
ESi is a highly respected field service provider to the pharmaceutical, biotech and medical device industries specializing in preventative and corrective maintenance, calibration and metrology, certification, validation and technical staffing. ESi is an ISO 9001 registered company and has earned ISO/IEC 17025 Accreditation from A2LA.
The acquisition of ESi represents the continued execution of Ellab’s corporate strategy of expanding its field services towards becoming a full solution provider in key markets within the life sciences industry. Ellab has rapidly grown organically in the US since making the successful strategic choice of expanding into validation services in late 2016 but looks to expand upon its service capabilities through acquisitions.
With the addition of ESi, Ellab US will grow from 180 to 205 employees. Including the ESi team, Ellab’s global field service organization is now counting close to 360 employees and the total headcount for the Ellab Group is 750.
In addition to Ellab’s validation and monitoring solutions as well as the strengthening of CQV services with the acquisition of ICQ earlier this month, the combined teams can offer a much stronger field service portfolio of validation, accredited field & lab calibration, preventative maintenance, technical staffing and certification. Combing ESi’s vast experience in the added segments with Ellab’s leading equipment and software, Ellab US will continue to rapidly grow its customer relationships and infrastructure.
“We are thrilled to welcome ESi’s outstanding team and expertise into the Ellab family. Adding their wide variety of skill sets and services into our total offering will continue to broaden the services Ellab can offer, providing more benefit to our clientele as well as individuals within the Ellab and ESi organizations. We look forward to cementing our position as a valued strategic partner in the life sciences market with this key addition to the team.” – Tim Paymaster, President and Chief Commercial Officer, Ellab, Inc.
The owner of ESi, Joseph C. Morwald, will continue within the management team in Ellab US.
This is Ellab’s second acquisition in the US and the 13th globally under EQT’s ownership. Working with EQT has allowed Ellab to continually welcome more great teams to join the Ellab family and grow to address customers’ needs across the globe.
Ellab provides world-leading validation, monitoring and calibration solutions and services, as well as GMP consulting, to life science and food manufacturing companies across the globe – allowing us to build confidence in consumer safety, together.
In September 2019, Ellab was acquired by the EQT Mid-Market Europe Fund (“EQT”).